Faes Farma, S.A. (BME:FAE)
4.205
+0.040 (0.96%)
May 15, 2025, 1:31 PM CET
Faes Farma Revenue
Faes Farma had revenue of 153.00M EUR in the quarter ending March 31, 2025, with 10.05% growth. This brings the company's revenue in the last twelve months to 524.02M, up 8.70% year-over-year. In the year 2024, Faes Farma had annual revenue of 510.04M with 7.81% growth.
Revenue (ttm)
524.02M
Revenue Growth
+8.70%
P/S Ratio
2.47
Revenue / Employee
295.22K
Employees
1,775
Market Cap
1.30B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 510.04M | 36.95M | 7.81% |
Dec 31, 2023 | 473.09M | 11.38M | 2.46% |
Dec 31, 2022 | 461.72M | 33.08M | 7.72% |
Dec 31, 2021 | 428.64M | 17.15M | 4.17% |
Dec 31, 2020 | 411.49M | 28.30M | 7.39% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.21B |
Laboratorios Farmaceuticos Rovi | 767.47M |
Almirall | 990.63M |
Pharma Mar | 175.75M |
Clínica Baviera | 265.72M |
Laboratorio Reig Jofre | 338.90M |
Atrys Health | 218.10M |
Oryzon Genomics | 7.36M |